Description
The abstract notes that combined treatment results in long-term survival for ‘some patients’ with IDH-mutant tumors, but doesn’t explain what distinguishes these exceptional responders. Understanding these mechanisms could identify biomarkers for prognosis and guide personalized treatment strategies.
Gap type: unexplained_observation Source paper: Primary brain tumours in adults. (None, None, PMID:37738997)